AMPH Amphastar Pharmaceuticals, Inc.

28.11USD-5.39%Mkt Cap: 1.20B USDP/E: 12.89

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. I…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap1.20B USD
Enterprise Value1.73B USD
Revenue (TTM)745.79M USD
Gross Profit356.06M USD
Net Income (TTM)98.09M USD
Revenue/Share16.81 USD
Last Price28.11 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.89
P/E (Forward)8.38
PEG—
EV/EBITDA8.71
EV/Revenue2.32
P/S1.61
P/B1.47
EPS (TTM)2.18 USD
EPS (Forward)3.35 USD
52W Range
16.6581% of range30.79
52W High30.79 USD
52W Low16.65 USD
Profitability
Gross Margin49.46%
Oper. Margin18.74%
EBITDA Margin26.59%
Profit Margin13.63%
ROE12.44%
ROA6.02%
ROIC9.59%
ROCE9.54%
Growth
Revenue Growth8.20%
Earnings Growth135.10%
Cash Flow & Leverage
Operating CF156.12M USD
CapEx (TTM)37.13M USD
FCF Margin1.23%
FCF Yield0.77%
Net Debt461.06M USD
Net Debt/EBITDA2.32
Net Debt/FCF50.11
Balance Sheet
Debt/Equity0.83
Current Ratio3.32
Quick Ratio2.29
Book Value/Sh19.10 USD
Cash/Share5.41 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)24.50 USD
Upside (mean)-12.8%
Target Range20.00 USD – 30.00 USD
20.00-12.8% to mean30.00
# Analysts6
Ownership
Shares Out.42.65M
Float31.41M
Insiders30.72%
Institutions70.55%
Short Interest
Short Ratio10.3d
Short % Float21.71%
Short % Out.9.99%
Shares Short4.26M
Short (prev mo.)4.41M
Technical
SMA 5026.07 (+7.8%)
SMA 20022.37 (+25.7%)
Beta0.94
S&P 52W Chg12.08%
Avg Vol (30d)449.69K
Avg Vol (10d)554.34K
Technical Indicators
RSI (14)53.4
MACD0.8833
MACD Signal0.9085
MACD Hist.-0.0251
BB Upper30.66 USD
BB Middle27.84 USD
BB Lower25.03 USD
BB Width20.21%
ATR (14)1.122 USD
Vol Ratio (20d)1.36x

About Amphastar Pharmaceuticals (NASDAQ: AMPH)

›

Amphastar Pharmaceuticals (NASDAQ: AMPH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 1,976 employees.

The shares were at 28.11 USD on 19 November 2026, up 11.3% over 52 weeks. Its 52-week range is 16.65 USD to 30.79 USD: the price is 8.7% below the high and 68.8% above the low.

At a market capitalisation of 1.20B USD, it trades at 12.9 times trailing earnings and 8.4 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 48% for AMPH.

Amphastar Pharmaceuticals reports return on equity of 12.4%, an operating margin of 18.7% and revenue up 8.2% year over year.

Its debt exceeds its cash by 461.06M USD, a debt-to-equity ratio of 0.83. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Hold; their mean price target of 24.50 USD is 12.8% below the current price. The next earnings report is expected on 25 February 2027.